Bayer Plc, Gastrografin gastroenteral solution, Urografin 150 infusion and Urografin 150 injection recalled
Class 3 medicines recall: The MHRA has issued a Class 3 medicines recall for Bayer Plc Gastrografin gastroenteral solution, Urografin 150 infusion and Urografin 150 injection.
Published: 12 February 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 3 Medicines Recall for various products manufactured by Bayer Plc.
Bayer Plc is recalling specific batches of Gastrografin gastroenteral solution, Urografin 150 infusion and Urografin 150 injection as a precautionary measure due to the identification of an impurity above the acceptable limit. The recall is at pharmacy and wholesaler level.
Pharmacists are advised to stop supplying the affected batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Further information, advice and details of the affected batches can be found on the MHRA website.